| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 745321 | Null | 0.0295480456086945 | 0.017275642 |
| NSC 749160 | Null | 0.0295480456086945 | 0.1032841 |
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0295480456086947 | 0.024794323 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0295480456086947 | -0.044876113 |
| NSC 135077 | BERSALDEGENIN 1,3,5-ORTHOACETATE | 0.0295480456086947 | 0.046603607 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0295480456086947 | 0.13860603 |
| NSC 346098 | Null | 0.0295480456086947 | 0.22283206 |
| NSC 618770 | Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide | 0.0295480456086947 | 0.091278842 |
| NSC 622115 | Null | 0.0295480456086947 | 0.026464119 |
| NSC 623606 | 7-Nitro-1,2,4-benzotriazin-3-amine-1,4-dioxide | 0.0295480456086947 | 0.098013496 |